Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 8 (August)

1. Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases.
   Am J Surg Pathol, 31(8): 1238-45. [Abstract] [Full-text]
2. The impact of margins on outcome after hepatic resection for colorectal metastasis.
   Ann Surg, 246(2): 295-300. [Abstract] [Full-text]
3. Activities of daily living and quality of life of elderly patients after elective surgery for gastric and colorectal cancers.
   Ann Surg, 246(2): 222-8. [Abstract] [Full-text]
4. Are we undertreating rectal cancer in the elderly? An epidemiologic study.
   Ann Surg, 246(2): 215-21. [Abstract] [Full-text]
5. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial.
   Ann Surg, 246(2): 207-14. [Abstract] [Full-text]
6. Hepatic resection for colorectal metastases: value for risk scoring systems?
   Ann Surg, 246(2): 183-91. [Abstract] [Full-text]
7. Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.
   Obstet Gynecol, 110(2): 543-5. [Abstract] [Full-text]
8. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
   J Immunother (1997), 30(6): 614-23. [Abstract] [Full-text]
9. Colorectal carcinoma rearranges cell surface protein topology and density in CD4+ T cells.
   Biochem Biophys Res Commun, 361(1): 202-7. [Abstract] [Full-text]
10. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women.
    Cancer Res, 67(15): 7534-9. [Abstract] [Full-text]
11. A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.
    Cancer Res, 67(15): 7477-86. [Abstract] [Full-text]
12. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Cancer Res, 67(15): 7147-54. [Abstract] [Full-text]
13. Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells.
    Cancer Res, 67(15): 7088-94. [Abstract] [Full-text]
14. Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy.
    J Surg Oncol, 96(2): 113-7. [Abstract] [Full-text]
15. Combined liver and lung metastasectomy through an exclusive transthoracic approach.
    J Surg Oncol, 96(2): 178-82. [Abstract] [Full-text]
16. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Gastroenterology, 133(2): 599-607. [Abstract] [Full-text]
17. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
    Gastroenterology, 133(2): 393-402. [Abstract] [Full-text]
18. Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells.
    Genes Chromosomes Cancer, 46(10): 865-74. [Abstract] [Full-text]
19. The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study.
    Invest New Drugs, 25(5): 479-85. [Abstract] [Full-text]
20. Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
    Invest New Drugs, 25(5): 411-6. [Abstract] [Full-text]
21. First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer.
    Cancer, 110(4): 752-8. [Abstract] [Full-text]
22. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    J Clin Oncol, 25(23): 3534-42. [Abstract] [Full-text]
23. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
    J Clin Oncol, 25(23): 3469-74. [Abstract] [Full-text]
24. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    J Clin Oncol, 25(23): 3462-8. [Abstract] [Full-text]
25. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    J Clin Oncol, 25(23): 3456-61. [Abstract] [Full-text]
26. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Dig Dis Sci, 52(9): 2287-91. [Abstract] [Full-text]
27. Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway.
    Dig Dis Sci, 52(9): 2292-300. [Abstract] [Full-text]
28. Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.
    Dig Dis Sci, 52(9): 2305-11. [Abstract] [Full-text]
29. Screening for colorectal cancer in personnel of an academic medical center.
    Dig Dis Sci, 52(9): 2301-4. [Abstract] [Full-text]
30. Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model.
    Cancer Chemother Pharmacol, 60(5): 651-60. [Abstract] [Full-text]
31. Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 60(5): 661-70. [Abstract] [Full-text]
32. The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry.
    Am J Surg, 194(3): 349-54. [Abstract] [Full-text]
33. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum.
    Am J Surg, 194(3): 294-8. [Abstract] [Full-text]
34. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer.
    Mutat Res, 622(1): 14-8. [Abstract] [Full-text]
35. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
    JAMA, 298(7): 754-64. [Abstract] [Full-text]
36. Dietary choline and betaine and the risk of distal colorectal adenoma in women.
    J Natl Cancer Inst, 99(16): 1224-31. [Abstract] [Full-text]
37. Computational identification of candidate loci for recessively inherited mutation using high-throughput SNP arrays.
    Bioinformatics, 23(15): 1952-61. [Abstract] [Full-text]
38. Altered endothelin receptor subtypes in colorectal cancer.
    Eur J Gastroenterol Hepatol, 19(9): 775-82. [Abstract] [Full-text]
39. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Clin Cancer Res, 13(16): 4786-94. [Abstract] [Full-text]
40. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.
    Cancer Res, 67(16): 7917-22. [Abstract] [Full-text]
41. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
    Cancer Res, 67(16): 7875-84. [Abstract] [Full-text]
42. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.
    Cancer Res, 67(16): 7865-74. [Abstract] [Full-text]
43. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
    Cancer Res, 67(16): 7703-12. [Abstract] [Full-text]
44. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy.
    Cancer Res, 67(16): 7646-53. [Abstract] [Full-text]
45. Involvement of RNA helicases p68 and p72 in colon cancer.
    Cancer Res, 67(16): 7572-8. [Abstract] [Full-text]
46. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    J Clin Oncol, 25(24): 3732-8. [Abstract] [Full-text]
47. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    J Clin Oncol, 25(24): 3726-31. [Abstract] [Full-text]
48. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.
    J Clin Oncol, 25(24): 3712-8. [Abstract] [Full-text]
49. Consumption of fish and risk of colon cancer in the Norwegian Women and Cancer (NOWAC) study.
    Br J Nutr, 98(3): 576-82. [Abstract] [Full-text]
50. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
    Clin Chem, 53(9): 1646-51. [Abstract] [Full-text]
51. Effect of slice thickness and primary 2D versus 3D virtual dissection on colorectal lesion detection at CT colonography in 452 asymptomatic adults.
    AJR Am J Roentgenol, 189(3): 672-80. [Abstract] [Full-text]
52. ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.
    Int J Cancer, 121(8): 1710-6. [Abstract] [Full-text]
53. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
    Int J Cancer, 121(8): 1670-9. [Abstract] [Full-text]
54. The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk.
    Int J Cancer, 121(8): 1744-8. [Abstract] [Full-text]
55. PIK3CA mutation is predictive of poor survival in patients with colorectal cancer.
    Int J Cancer, 121(8): 1771-8. [Abstract] [Full-text]
56. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
    Cancer Lett, 255(2): 295-9. [Abstract] [Full-text]
57. Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.
    Int J Cancer, 121(8): 1717-23. [Abstract] [Full-text]
58. Tumor-initiating potency of a novel heterocyclic amine, aminophenylnorharman in mouse colonic carcinogenesis model.
    Int J Cancer, 121(8): 1659-64. [Abstract] [Full-text]
59. Diosgenin, a naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells.
    Cancer Lett, 255(2): 194-204. [Abstract] [Full-text]
60. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells.
    Int J Cancer, 121(8): 1690-6. [Abstract] [Full-text]
61. Curcumin for chemoprevention of colon cancer.
    Cancer Lett, 255(2): 170-81. [Abstract] [Full-text]
62. Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
    Cancer Immunol Immunother, 56(11): 1795-805. [Abstract] [Full-text]
63. Thermal sensitization through ROS modulation: a strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy.
    Surgery, 142(3): 384-92. [Abstract] [Full-text]
64. Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
    J Clin Oncol, 25(25): 3930-5. [Abstract] [Full-text]
65. Laparoscopic hand-assisted extended right hemicolectomy for cancer management.
    Surg Endosc, 21(9): 1654-6. [Abstract] [Full-text]
66. Medially approached radical lymph node dissection along the surgical trunk for advanced right-sided colon cancers.
    Surg Endosc, 21(9): 1657. [Abstract] [Full-text]
67. Laparoscopic lymphatic mapping and sentinel lymph node detection in colon cancer: technical aspects and preliminary results.
    Surg Endosc, 21(9): 1567-71. [Abstract] [Full-text]
68. Overexpression of CYP2A6 in human colorectal tumors.
    Cancer Sci, 98(10): 1582-5. [Abstract] [Full-text]
69. Involvement of cyclooxygenase-2 in the tumor site-dependent production of parathyroid hormone-related protein in colon 26 carcinoma.
    Cancer Sci, 98(10): 1563-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.